Chemotherapy-induced Symptoms in Sarcoma Patients and the Impact of Tumor Burden

Completed

Conditions studied: Soft Tissue Sarcoma

In brief

Assessments (survey data) in this study are designed to sample the symptom burden of patients undergoing adjuvant and neoadjuvant chemotherapy in the hospital. There will be no change in the treatment plan for these patients.

Key facts

Study ID

NCT01136824

Run by

University of Pittsburgh

People needed

11

Starts

2010-06-01

Expected to finish

2014-05-01

Last updated by the study team

2016-07-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who are receiving doxorubicin plus ifosfamide (AI)

You may not qualify if…

• There is no exclusion criteria

Where it is running

• University of Pittsburgh, Hillman Cancer Center — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.